title: The time for a confirmative necrotizing enterocolitis probiotics prevention trial in the extremely low birth weight infant in North America is now!
authors.affiliation: Research Institute, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; Division of Pediatrics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. Electronic address: thoab@telia.com.
authors.forename: Thomas R
authors.initials: TR
authors.lastname: Abrahamsson
authors.affiliation: Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland.
authors.forename: Samuli
authors.initials: S
authors.lastname: Rautava
authors.affiliation: Research Institute, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Aideen M
authors.initials: AM
authors.lastname: Moore
authors.affiliation: University of Florida, Gainesville, FL.
authors.forename: Josef
authors.initials: J
authors.lastname: Neu
authors.affiliation: Research Institute, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Philip M
authors.initials: PM
authors.lastname: Sherman
mesh_terms: D002986:Clinical Trials as Topic; D020345:Enterocolitis, Necrotizing / Q000517:prevention & control*; D006801:Humans; D052577:Infant, Extremely Low Birth Weight; D007231:Infant, Newborn; D007234:Infant, Premature; D009656:North America; D019936:Probiotics / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome